Found 200 matching trials
The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial NA Continued uncertainty exists over benefits of early intensive blood pressur...
Show More Location
West China Hospital
Learn More & Join Trial
Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants NA The study is assessing the impact of an expert eCRF on the management of se...
Show More Location
Centre Hospitalier d'Avignon
Learn More & Join Trial
Phase I/IIa Study of FIXFc in Hemophilia B Patients PHASE1 The primary objective of the study is to assess safety of FIXFc at doses ra...
Show More Location
RUSH University Medical Center
Learn More & Join Trial
Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B PHASE1 A Phase 1/2, open-label, dose-finding safety study of single ascending dose...
Show More Location
Arkansas Children's Hospital
Learn More & Join Trial
Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes N/A The primary objective of the study is to evaluate the effectiveness of prop...
Show More Learn More & Join Trial
Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B PHASE3 The primary objective of the study was to evaluate the safety of recombinan...
Show More Learn More & Join Trial
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia PHASE3 This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Show More Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Learn More & Join Trial
Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban PHASE3 An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to...
Show More Location
Shands University of Florida
Learn More & Join Trial
An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding N/A This observational cohort study is designed to obtain product safety inform...
Show More Learn More & Join Trial
Reliability and Validity of the Turkish Version of the PedHAL N/A This study aimed to establish the validity and reliability of the Turkish v...
Show More Location
Hasan Kalyoncu University
Learn More & Join Trial